Tennessee Oncology, PLLC - Smyrna

Clinical research site in Smyrna, Tennessee · 300 STONECREST BLVD, STE 400, SMYRNA, TN 37167-5688 · (615) 355-1770

Part of Tennessee Oncology

As of July 2026, 4 paid clinical trials are recruiting at Tennessee Oncology, PLLC - Smyrna in Smyrna, Tennessee. Active studies at this site cover conditions such as Advanced/Metastatic Urothelial Cancer, Cancer of the Prostate and Hormone Sensitive Prostate Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Tennessee Oncology, PLLC - Smyrna (4)

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

for Urothelial Cancer

74 locations incl. Fayetteville

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07421700·Phase 1, Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

for Carcinoma, Renal Cell

109 locations incl. Phoenix

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07227415·Phase 1, Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

for Non-small Cell Carcinoma

133 locations incl. Alabaster

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07144280·Phase 3·Recruiting·Listed Aug 2025

Apply to this trial

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

for Metastatic Castration Sensitive Prostate Cancer (mCSPC)

122 locations incl. Huntsville

Sponsor: Pfizer

Sex: Male·Age: 18+

Code: NCT07028853·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

More research sites in Smyrna

DelRicht Research - Thompson's Station (2 trials)
Advancing Vision Research (1 trial)
Clinical Trial Site (1 trial)
DelRicht Research (1 trial)
Delricht Research - Smyrna (1 trial)
Local Institution - 007-928-I (1 trial)
Spine and Pain Physicians Surgery Center (1 trial)
Tennessee Oncology - Smyrna Clinic (1 trial)
Tennessee Oncology, PLLC- Smyrna (1 trial)

Explore more

Paid clinical trials in Smyrna, TN · Tennessee clinical trials